Thanks. From recent negative PIII Bayer sorafenib trial in...

Thanks. From recent negative PIII Bayer sorafenib trial in HCC:

"Hepatocellular carcinoma is the most common form of liver cancer and is responsible for about 80 percent of the primary malignant liver tumors in adults.1,2 Liver cancer is the sixth most common cancer in the world and is the second most common cause of death from cancer worldwide. More than 780,000 cases of liver cancer are diagnosed worldwide each year (more than 395,000 in China, 52,000 in the European Union and 30,000 in the United States) and the incidence is increasing. In 2012, approximately 746,000 people died of liver cancer including approximately 383,000 in China, 48,000 in the European Union and 24,000 in the United States."

Low double digits looks enticing.....